This study was conducted at the National Institute ofMalariology, Parasitology and Entomology between February and May, 2021. The compound 10^ - [(2fi-hydroxy-3'-imidazol) propyl] deoxoartemisinin (32) was treated orally in experimental rabbits in order to examine whether it affected rabbits' hematopoieticj unctions or not.